MEDEVALMedical Evaluation
MEDEVALMedical Evaluation Report with Special Reference to the Allegation
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
CB2 announced on 20 March that it had entered into a binding letter of intent to acquire the assets of MedEval LLC.
21 March 2019 - Canada-based CB2 Insights (CSE: CBII), a provider of predictive analytics tools, data-driven software and comprehensive services across the cannabis value chain, has clarified the terms with respect to its pending acquisition of medical cannabis evaluation clinic group MedEval LLC.
A Phase I trial examining subcutaneous administration of PI-88 in healthy volunteers is nearing completion at the specialist clinical research organization, Medeval, in the United Kingdom.
Trials for the Amvac Chemical Corporation were carried out by the company Medeval after it claimed dichloros was used in the treatment of Alzheimer's Disease.